Saba Capital Management, L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Saba Capital Management, L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$3,502,827
+1.8%
323,1420.0%0.08%
-6.7%
Q2 2023$3,441,462
-68.4%
323,142
-69.0%
0.09%
-56.7%
Q1 2023$10,876,862
-40.8%
1,041,845
-41.9%
0.21%
-16.5%
Q4 2022$18,384,330
+2.2%
1,791,8450.0%0.25%
+22.7%
Q3 2022$17,981,000
+0.2%
1,791,8450.0%0.20%
-2.9%
Q2 2022$17,945,000
+17.9%
1,791,845
+16.4%
0.21%
-3.7%
Q1 2022$15,215,0001,540,0120.22%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders